BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 29, 2026
Home » Blogs » BioWorld MedTech Perspectives » Rising to the Challenge

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Rising to the Challenge

Dec. 14, 2012
By Amanda Pedersen

Amanda at the finish line of the Rock & Roll Las Vegas Half-Marathon, a Team Challenge event to benefit the Crohn's and Colitis Foundation of America.

When I signed up for my first half-marathon, which took place recently on the Las Vegas strip at night, I knew I was in for a tremendous challenge. But I had no idea I would be finishing the 13.1 mile race while battling a small bowel obstruction.

While this setback easily could have sidelined me from the race, it made me all the more determined to see it through. The idea of letting down all the people who supported me for this event with kindness and generosity was more painful, to me, than the obstruction itself.

You see, this was Team Challenge, a fundraising event for the Crohn’s and Colitis Foundation of America (CCFA), a cause I truly believe in not only for myself, but for the millions of other people around the globe who suffer from these diseases, collectively known as inflammatory bowel disease (IBD).

One of the brighter parts of my Team Challenge experience was the opportunity to meet in person someone who has become a personal hero because of everything he does for IBD patients, Dewey Thom. I met Dewey about a year ago through a mobile app called GI Monitor. When I felt a major obstruction building the night before the race, Dewey was the one I called in the middle of the night for advice. Between him, our CCFA team manager and our coach, I was quickly put in touch with a gastroenterologist from the University of California Los Angeles who was volunteering his time and services during the event.

The following is what Dewey shared on GI Monitor a few days after the race: “To fully appreciate Amanda’s accomplishment you should know that she has been largely on an Ensure diet for months, and not able to fully train … She fought off an obstruction Saturday night in the wee hours of the morning, with full onset of symptoms including nausea, bloating, pain etc., probably ‘slept’ for a few hours that morning, then with CCFA doc clearance was able to fully complete 13.1 miles.”

Dewey knew I was determined to finish the Team Challenge half-marathon regardless of training or fundraising shortcomings, because he knows how much it means to me to finally be able to actively fight back against Crohn’s and colitis.

In the past year, bowel obstructions have become a near-constant part of my life. A complication, I believe, from the multiple surgeries I went through ten years ago for ulcerative colitis. To read more about my battle with the disease click here.

“And notwithstanding being short of her fundraising requirement, she made her way to Vegas and crossed the finish line, hurdling those challenges with grace and aplomb,” Dewey said. “And if you have the means or desire to help her to her goal, I include her page here as she’s too modest to. Hell of a job Amanda. I cheer your accomplishment and thank you for your endurance!”

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 29, 2026.
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing